Ondansetron

VOMIVIB

null
COMPOSITION
Ondansetron2MG/ML
SPECIFICATION
FORMINJECTABLE
PACKING 10’s
PACKING TYPE
MRP106

DESCRIPTION

A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties. [PubChem]

SIDE EFFECTS

Low blood pressure and fainting, sudden blindness, severe constipation

INDICATION

For the prevention of nausea and vomiting associated with emetogenic cancer chemotherapy, postoperation, and radiation. Also used for the treatment of postoperative nausea and vomiting.

Important Notice:-  The Database is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

null